PL444571A1 - 2-[(E)-2-(2-metoksyfenylo)etenylo]pirydo[2,3-d]pirymidino-4-ylo-4-metylobenzeno-1-sulfonian i jego zastosowanie - Google Patents

2-[(E)-2-(2-metoksyfenylo)etenylo]pirydo[2,3-d]pirymidino-4-ylo-4-metylobenzeno-1-sulfonian i jego zastosowanie Download PDF

Info

Publication number
PL444571A1
PL444571A1 PL444571A PL44457123A PL444571A1 PL 444571 A1 PL444571 A1 PL 444571A1 PL 444571 A PL444571 A PL 444571A PL 44457123 A PL44457123 A PL 44457123A PL 444571 A1 PL444571 A1 PL 444571A1
Authority
PL
Poland
Prior art keywords
cell structures
methylbenzene
pyrido
ethenyl
pyrimidin
Prior art date
Application number
PL444571A
Other languages
English (en)
Other versions
PL246646B1 (pl
Inventor
Katarzyna Malarz
Patrycja Rawicka
Jacek Mularski
Anna Mrozek-Wilczkiewicz
Original Assignee
Uniwersytet Śląski W Katowicach
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Śląski W Katowicach filed Critical Uniwersytet Śląski W Katowicach
Priority to PL444571A priority Critical patent/PL246646B1/pl
Publication of PL444571A1 publication Critical patent/PL444571A1/pl
Publication of PL246646B1 publication Critical patent/PL246646B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10—Non-macromolecular compounds
    • C09K2211/1018—Heterocyclic compounds
    • C09K2211/1025—Heterocyclic compounds characterised by ligands
    • C09K2211/1059—Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Materials Engineering (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest 2-[(E)-2-(2-metoksyfenylo)etenylo]pirydo[2,3d-]pirymidino-4-ylo-4-metylobenzeno-1-sulfonian oraz jego zastosowanie jako barwnika fluorescencyjnego do barwienia biologicznych struktur komórkowych, korzystnie do barwienia błoniastych struktur komórkowych, najkorzystniej do barwienia błoniastych struktur komórkowych nowotworów nabłonkowych płuc lub błoniastych struktur komórkowych nowotworów mózgu, lub błoniastych struktur komórkowych nowotworów piersi.
PL444571A 2023-04-25 2023-04-25 2-[(E)-2-(2-metoksyfenylo)etenylo]pirydo[2,3-d]pirymidino- -4-ylo-4-metylobenzeno-1-sulfonian i jego zastosowanie PL246646B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL444571A PL246646B1 (pl) 2023-04-25 2023-04-25 2-[(E)-2-(2-metoksyfenylo)etenylo]pirydo[2,3-d]pirymidino- -4-ylo-4-metylobenzeno-1-sulfonian i jego zastosowanie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL444571A PL246646B1 (pl) 2023-04-25 2023-04-25 2-[(E)-2-(2-metoksyfenylo)etenylo]pirydo[2,3-d]pirymidino- -4-ylo-4-metylobenzeno-1-sulfonian i jego zastosowanie

Publications (2)

Publication Number Publication Date
PL444571A1 true PL444571A1 (pl) 2024-10-28
PL246646B1 PL246646B1 (pl) 2025-02-17

Family

ID=93289644

Family Applications (1)

Application Number Title Priority Date Filing Date
PL444571A PL246646B1 (pl) 2023-04-25 2023-04-25 2-[(E)-2-(2-metoksyfenylo)etenylo]pirydo[2,3-d]pirymidino- -4-ylo-4-metylobenzeno-1-sulfonian i jego zastosowanie

Country Status (1)

Country Link
PL (1) PL246646B1 (pl)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017014601A1 (ko) * 2015-07-23 2017-01-26 서울대학교 산학협력단 인돌리지노[3,2-ｃ]퀴놀린계 형광 프로브
PL233179B1 (pl) * 2016-10-31 2019-09-30 Univ Slaski Nowe zastosowanie pochodnych para-iminostyrylochinoliny

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017014601A1 (ko) * 2015-07-23 2017-01-26 서울대학교 산학협력단 인돌리지노[3,2-ｃ]퀴놀린계 형광 프로브
PL233179B1 (pl) * 2016-10-31 2019-09-30 Univ Slaski Nowe zastosowanie pochodnych para-iminostyrylochinoliny

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BARBARA CZAPLIŃSKA I IN.: "Scientific Reports 2019, 9:15304", „ACID SELECTIVE PRO-DYE FOR CELLULAR COMPARTMENTS" *

Also Published As

Publication number Publication date
PL246646B1 (pl) 2025-02-17

Similar Documents

Publication Publication Date Title
Yang et al. Nanofiber membrane supported lung-on-a-chip microdevice for anti-cancer drug testing
Paolino et al. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
MX2019005125A (es) Variantes de superficie celular discernibles inmunologicamente para uso en terapia celular.
PE20091320A1 (es) Derivados de carboxamidas azabiciclicas, su preparacion y su aplicacion en terapautica
AR119997A1 (es) Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecíficos anti-klk5 / klk7 y métodos de uso
PE20181345A1 (es) Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso en el tratamiento del cancer
WO2006047484A3 (en) Molecular analysis of cellular fluid and liquid cytology specimens for clinical diagnosis, characterization, and integration with microscopic pathology evaluation
PH12021552568A1 (en) Pyrrolotriazine derivatives for treating kit-and pdgfra-mediated diseases
WO2022115388A8 (en) Polymer dyes
BR112018076528A2 (pt) composições e métodos para diagnosticar cânceres de pulmão usando perfis de expressão gênica
WO2020023911A3 (en) Near-infrared nerve-sparing fluorophores
WO2020115286A3 (en) Cell-permeable fluorogenic fluorophores
PL444571A1 (pl) 2-[(E)-2-(2-metoksyfenylo)etenylo]pirydo[2,3-d]pirymidino-4-ylo-4-metylobenzeno-1-sulfonian i jego zastosowanie
BR112021023794A2 (pt) Agente de direcionamento de antígeno, molécula de ácido nucleico isolada, composição farmacêutica, célula citotóxica, e, métodos para produzir uma célula citotóxica, para realizar uma terapia celular adotiva, para realizar uma imunoterapia e para detectar câncer em um sujeito mamífero
BR0303912A (pt) Composição para o condicionamento, composição para o condicionamento durável, método para o condicionamento, método para o condicionamento durável, método para o cuidado ou tratamento e kit para o cuidado, tratamento, condicionamento ou condicionamento durável
PL444568A1 (pl) 4-[(2-chlorofenylo)sulfanylo]-2-[(E)-2-(2-metoksyfenylo)etenylo]pirydo[2,3-d]pirymidyna oraz jej zastosowanie
Kuroda et al. Invasive micropapillary carcinoma of the breast: an immunohistochemical study of neoplastic and stromal cells
MX385110B (es) Compuestos de quinoxalina, método para preparar los mismos y uso de los mismos.
PL419317A1 (pl) Nowe zastosowanie pochodnych para-iminostyrylochinoliny
PL442750A1 (pl) 2,6-Diwinylowe pochodne ditlenku ditienotiofenu, sposób ich wytwarzania i zastosowanie
WO2023060695A1 (zh) 肝癌悬浮类器官的培养基和培养方法
PL426138A1 (pl) Sposób diagnozowania boreliozy, sposób różnicowego diagnozowania boreliozowego zapalenia stawów, lizofosfatydyloetanoloamina do zastosowania jako biomarker, zestaw do diagnozowania boreliozy i zestaw do różnicowego diagnozowania boreliozowego zapalenia stawów
Daniele et al. Pleomorphic adenoma and adenoid‐cystic carcinoma of salivary glands: immunohistochemical assessment of proliferative activity in comparison with flow‐cytometric study
PL420283A1 (pl) Nowa pochodna styrylochinoliny oraz jej zastosowanie
PL419320A1 (pl) Nowa pochodna para-iminostyrylochinoliny oraz jej zastosowanie